Tissue specificity in cancer is best evidenced by hereditary cancer predisposition syndromes in which the underlying gene defects, such as mutations in APC, BRCA1, and VHL, are associated with a high risk of developing tissue-specific cancer types [45]. This evidence concerns the gene APC and cancer.